Argenx to acquire Unnatural Products
Argenx says the acquisition will add a peptide discovery engine and broaden its immunology capabilities.
Story updates
06:02:19 AM UTC
SquawkNews
argenx agreed to acquire all remaining shares of Unnatural Products, Inc., valuing UNP at up to approximately $1.15B: $550M upfront in cash and up to $595M in development and regulatory milestones. Closing is expected by year-end, subject to customary conditions.Material DetailsContext by AI Analys…